Tolerance of dinutuximab therapy for treatment of high‐risk neuroblastoma in two patients with end‐stage renal disease on dialysis-Reference-Cited by-同舟云学术

Tolerance of dinutuximab therapy for treatment of high‐risk neuroblastoma in two patients with end‐stage renal disease on dialysis

Published:2020-12-31 Issue:3 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Emberesh Myesa¹²^ORCID,Rubinstein Jeremy D.¹²^ORCID,Young Jennifer³^ORCID,Benoit Stefanie W.¹⁴⁵,Dandoy Christopher E.¹⁵^ORCID,Weiss Brian D.¹²

Affiliation:

1. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati Ohio

2. Division of Oncology Cancer and Blood Disease Institute Cincinnati Children's Hospital Medical Center Cincinnati Ohio

3. Division of Pharmacy Cincinnati Children's Hospital Medical Center Cincinnati Ohio

4. Division of Nephrology Cincinnati Children's Hospital Medical Center Cincinnati Ohio

5. Division of Bone Marrow Transplantation and Immune Deficiency Cancer and Blood Disease Institute Cincinnati Children's Hospital Medical Center Cincinnati Ohio

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28852

Reference17 articles.

1. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

2. Advances in Risk Classification and Treatment Strategies for Neuroblastoma

3. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

4. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults

5. Targeted Immunotherapy for High-Risk Neuroblastoma—The Role of Monoclonal Antibodies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors, impact and treatment of postoperative lymphatic leakage in children with abdominal neuroblastoma operated on by laparotomy;BMC Surgery;2024-05-29

2. A GD2-aptamer-mediated, self-assembling nanomedicine for targeted multiple treatments in neuroblastoma theranostics;Molecular Therapy - Nucleic Acids;2021-12

3. Antineoplastics;Reactions Weekly;2021-04